Revolutionizing DKA Management with Subcutaneous Insulin

This chapter explores the shift towards using subcutaneous insulin as an effective alternative to intravenous therapy for managing Diabetic Ketoacidosis (DKA). It highlights recent research demonstrating comparable safety and efficacy, as well as the logistical benefits of this approach in emergency settings. The discussion emphasizes successful implementation strategies, patient considerations, and the importance of teamwork in achieving optimal outcomes.